A DAILY PILL CUT AN AVERAGE LITER OF VOLUME FROM SWOLLEN LEGS.
A small trial suggests the first medication for lymphedema may be getting closer.
An experimental daily pill aimed at a precise inflammatory pathway produced encouraging one-year results in people with lower-limb lymphedema.
WHAT HAPPENED
Twenty-three volunteers took acebilustat once daily for a year. On average, affected legs lost one liter of volume; skin thickness and scarring eased, and participants reported better quality of life. A separate placebo-controlled phase 2 study in upper-limb lymphedema is being analyzed.
WHY THIS IS HOPESLOP
There is still no approved medication for lymphedema. A targeted pill showing measurable changes in swelling and tissue damage — even in a small early trial — is the kind of progress that turns a lifelong wrapping routine into a plausible next chapter.
ORIGINAL SOURCEStanford MedicineRead the original report
A DAILY ALLEGATION OF PROGRESS.
One good thing from the internet, every day. Nothing else.